lactic acid has been researched along with amyloid beta-peptides in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia De Arriba, S; Huber, J; Kuhla, B; Loske, C; Münch, G; Schinzel, R | 1 |
| Deane, R; Hogg, E; Jovanovic, S; LaRue, B; Maness, L; Maurer, C; Sagare, A; Zlokovic, BV | 1 |
| Chan, C; Melrose, J; Patil, S | 1 |
| Brody, DL; Esparza, TJ; Holtzman, DM; Magnoni, S; Schwetye, KE; Spinner, ML; Stocchetti, N; Zipfel, GJ | 1 |
| Weigel-Van Aken, KA; Xiang, Y; Xu, G | 1 |
| Fu, F; He, J; Li, Y; Liu, W; Sun, K; Tian, J; Ye, L; Yu, P; Yu, X | 1 |
| Al-Abbasi, FA; Anwar, F; Bhatt, PC; Kumar, V; Panda, BP; Verma, A | 1 |
7 other study(ies) available for lactic acid and amyloid beta-peptides
| Article | Year |
|---|---|
Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y.
Topics: Adenosine Triphosphate; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Glucose; Glycation End Products, Advanced; Humans; Lactic Acid; Neurons; Peptide Fragments; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2004 |
Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoradiography; Blood-Brain Barrier; Brain Chemistry; Capillary Permeability; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Disease Models, Animal; Functional Laterality; Glycation End Products, Advanced; Humans; Iodine Isotopes; Lactic Acid; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron; Peptide Fragments; Perfusion; Permeability; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regional Blood Flow | 2004 |
Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons.
Topics: Adenosine Triphosphate; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Antimetabolites; Astrocytes; Cells, Cultured; Ceramides; Cerebral Cortex; Cycloserine; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glucose; L-Lactate Dehydrogenase; Lactic Acid; Neurons; Palmitic Acid; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2007 |
Amyloid-beta dynamics correlate with neurological status in the injured human brain.
Topics: Amyloid beta-Peptides; Brain; Brain Injuries; Extracellular Fluid; Glasgow Coma Scale; Glucose; Humans; Intracranial Hypertension; Lactic Acid; Microdialysis; Peptide Fragments; Pyruvic Acid | 2008 |
Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line, Tumor; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Hydrogen-Ion Concentration; Immunoprecipitation; Lactic Acid; Membrane Proteins; Microscopy, Fluorescence; Molecular Chaperones; Peptide Fragments; Protein Binding | 2010 |
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; GPI-Linked Proteins; Injections, Intramuscular; Lactic Acid; Male; Memory; Microspheres; Particle Size; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Technology, Pharmaceutical | 2013 |
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antifibrinolytic Agents; Calorimetry, Differential Scanning; Drug Delivery Systems; Drug Liberation; Fibrinolytic Agents; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Mixed Function Oxygenases; Nanoparticles; Peptide Fragments; Plaque, Amyloid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins; Spectroscopy, Fourier Transform Infrared; Subtilisins | 2017 |